134 related articles for article (PubMed ID: 1686232)
1. Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.
Eriksson UG; Lundahl J; Bäärnhielm C; Regårdh CG
Drug Metab Dispos; 1991; 19(5):889-94. PubMed ID: 1686232
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
Miniscalco A; Lundahl J; Regårdh CG; Edgar B; Eriksson UG
J Pharmacol Exp Ther; 1992 Jun; 261(3):1195-9. PubMed ID: 1602384
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver.
Niwa T; Tokuma Y; Nakagawa K; Noguchi H
Drug Metab Dispos; 1989; 17(1):64-8. PubMed ID: 2566472
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine.
Bäärnhielm C; Skånberg I; Borg KO
Xenobiotica; 1984 Sep; 14(9):719-26. PubMed ID: 6516445
[TBL] [Abstract][Full Text] [Related]
6. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of felodipine in liver microsomes from rat, dog, and man.
Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L
Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture.
Eriksson UG; Hoffmann KJ; Simonsson R; Regårdh CG
Xenobiotica; 1991 Jan; 21(1):75-84. PubMed ID: 2003369
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective glucuronidation of ofloxacin in rat liver microsomes.
Okazaki O; Kurata T; Hakusui H; Tachizawa H
Drug Metab Dispos; 1991; 19(2):376-80. PubMed ID: 1676640
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes.
Itoh K; Nishiya Y; Takasaki W; Adachi M; Tanaka Y
Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492
[TBL] [Abstract][Full Text] [Related]
13. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
Zhao XJ; Ishizaki T
J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
[TBL] [Abstract][Full Text] [Related]
14. Determination of felodipine enantiomers using chiral stationary phase liquid chromatography and gas chromatography/mass spectrometry, and the study of their pharmacokinetic profiles in human and dog.
Sakamoto T; Ohtake Y; Itoh M; Tabata S; Kuriki T; Uno K
Biomed Chromatogr; 1993; 7(2):99-103. PubMed ID: 8485383
[TBL] [Abstract][Full Text] [Related]
15. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.
Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD
Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955
[TBL] [Abstract][Full Text] [Related]
16. Influence of substrate configuration on chlorpheniramine N-demethylation by hepatic microsomes from rats, rabbits, and mice.
Thompson JA; Shioshita GW
Drug Metab Dispos; 1981; 9(1):5-9. PubMed ID: 6111432
[TBL] [Abstract][Full Text] [Related]
17. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
Kroemer HK; Fischer C; Meese CO; Eichelbaum M
Mol Pharmacol; 1991 Jul; 40(1):135-42. PubMed ID: 1857335
[TBL] [Abstract][Full Text] [Related]
18. Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist.
Karanam BV; Welch CJ; Reddy VG; Chilenski J; Biba M; Vincent S
Drug Metab Dispos; 2004 Oct; 32(10):1061-8. PubMed ID: 15229170
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
20. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
Echizen H; Mochizuki K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
